31
APPSw-NSE
APP
Transgene containing human APP (isoform 695) bearing the Swedish mutation under the control of neuron specific enolase (NSE) promoter. Targeted knock-in of the V642I mutation into exon 17 of the mouse APP gene using homologous recombination and the CreloxP system.
32
APP(V642I)KI APP
33
APP(V717I)
APP
Transgene containing human APP (isoform 695) with the London mutation driven by the Thy1 promoter.
The transgene overexpresses the mutant human amyloid protein
34
APP(V717I) x APP, precursor APP (isoform 695), which bears the London (V717I) PS1(A246E) PSEN1 mutation, and human presenilin-1 with the A246E mutation, both under the control of the neuron-specific murine Thy1 promoter.
35
Arc48 (APPSw/Ind/A APP rc)
A human APP minigene with the Swedish, Indiana, and Arctic mutations driven by the platelet-derived growth factor β-chain promoter.
36
ArcAβ
APP
Human APP695 transgene containing the Swedish (K670N/M671L) and Arctic mutation (E693G) was generated by site-directed mutagenesis. Homologous recombination was used to disrupt a 2kb section of
37
BACE1 Knock- BACE1 BACE1 containing exon 1 replacing it with a neomycin selection out cassette and the HSV thymidine kinse gene.
38
39
Cre mediated recombination was used to remove exon 6 of BACE2. A targeting vector containing a loxP site and hygromycin BACE2 Knock- BACE2 resistance gene flanked by FRT sites was introduced into intron 5 and a second loxP site was inserted within intron 6. out Heterozygous mice were crossed with mice expressing Cre under the ubiquitous phosphoglyc
erate kinase promoter to delete exon 6 in progeny. Construct encodes a fusion protein of the BRI protein and Aβ40 driven by the mouse prion promoter; Aβ40 is secreted through BRI-Aβ 40 proteolytic cleavage of the protein at a furin cleavage site (BRI2-Aβ 40) immediately preceding Aβ40. Construct encodes a fusion protein of the BRI protein and Aβ42 driven by the mouse prion promoter. Aβ42 is secreted through proteolytic cleavage of the protein at a furin cleavage site immediately preceding Aβ42. PS1 inactivation in neuronal progenitor cells (NPCs) and NPCPSEN1 derived neurons and glia was achieved by crossing a floxed PS1 mouse with a Nestin-Cre transgenic mice. Transgene of human APOE4 driven by the GFAP promoter; crossed to APOE knock-out mice. Transgene of human BACE driven by the prion protein (PrP) promoter.
40
BRI-Aβ 42 (BRI2-Aβ 42) CNSrestricted PS1 cKO GFAPAPOE4/APOE KO hBACE
41
42 43
APOE
BACE1

Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...
第二节 阿尔茨海默病(Alzheimer's disease,AD)阿尔茨海默病(Alzheimer's disease,AD) ,是发生于老年和老年前期、以 进行性认知功能障碍和行为损害为特征的中枢...
Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD Transgenic Mice Medicine ?...
阿尔茨海默病(Alzheimer’SDisease,AD)与动力相关蛋白1(dynamin—relatedprotein1,Drp1)_基础医学_医药卫生_专业资料。第3 0卷第 2期 201 3年 4月 生物学...
让我们向江教练致敬,并祝老年痴呆症患者早日康复! 治疗老年痴呆症的小偏方所谓的老年痴呆症,又称阿尔茨海默病(alzheimer's disease,ad)是发生在老年期及老年前期...
b.老年痴呆病 老年性痴呆病,分为阿尔茨海默病(Alzheimer’sdisease,AD)和血管性痴呆(VD) ,是一 种发病于老年期前后的原发性大脑退行性疾病。 近年来老年性痴呆...
老年痴呆症的护理 老年痴呆症又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期及老年前期的一种 原发性退行性脑病, 指的是一种持续性高级神经功能...
In order to study AD pathology and develop AD ...Using Tg6799 as a mouse model for AD research ...(Alzheimer’s disease,AD)又称老年痴呆症,是一...
Alzheimer's disease 老年痴呆症Alzheimer's disease 老年痴呆症隐藏>> review article Pathways towards and away from Alzheimer’s disease Mark P. Mattson ...
老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期 及老年前期的一种原发性退行性脑病,指 的是一种持续性高级神经功能活动障碍, 即在没...
热门文档